New York/Frankfurt | Reuters — German drugs and crop chemicals company Bayer has won over U.S. seeds firm Monsanto with an improved takeover offer of US$66 billion including debt, ending months of wrangling after increasing its bid for a third time. The $128 a share deal announced on Wednesday, up from Bayer’s previous offer of […] Read more
Bayer clinches Monsanto with raised US$66 billion bid
Bayer sweetens Monsanto bid as talks enter final stretch
Reuters — German pharmaceutical and crops manufacturer Bayer said on Monday that its negotiations with Monsanto had advanced, and that it was now willing to offer more than US$65 billion to acquire the world’s largest seeds company. Bayer’s announcement came as the gap in price expectations between the two companies has narrowed significantly, although important […] Read more
U.S. watchdog clears ChemChina’s takeover of Syngenta
Zurich | Reuters — A U.S. regulator has cleared ChemChina’s US$43 billion takeover of Swiss pesticides and seeds group Syngenta, the companies said Monday, boosting chances that the largest foreign acquisition ever by a Chinese company will go through. The decision should remove significant uncertainty over whether the acquisition of the world’s largest pesticides maker […] Read more
Monsanto reported giving Bayer limited access to its books
Frankfurt | Reuters — U.S. seed company Monsanto has given German suitor Bayer limited access to its books after turning down a sweetened US$64 billion takeover offer last month, two sources familiar with the situation told Reuters. The parties have not yet signed a non-disclosure agreement, which would allow Bayer to conduct due diligence, but […] Read more
Quarantined Washington wheat negative for GMO
Reuters — No genetically modified (GMO) wheat has been found in a Washington state farm’s crop tested after an unapproved biotech variety was discovered growing there in June, the U.S. Department of Agriculture said on Friday. The quarantined grain will be allowed to enter the marketplace, USDA said. USDA’s Animal and Plant Health Inspection Service […] Read more
Korea reports no GMO in U.S. wheat imports
Seoul | Reuters — South Korea has not detected any genetically modified wheat in tests on imports of wheat and flour from Washington state, after the discovery of unapproved GM wheat in the U.S. state prompted Japan and South Korea to suspend certain U.S. imports. South Korea, the fifth largest market for U.S. wheat, had […] Read more
Ontario farmers ready for Roundup Ready 2 Xtend soy
CNS Canada — Soybean producers in Ontario are eager to start planting next season with new ammunition against Canada fleabane. Monsanto’s Roundup Ready 2 Xtend soybeans, genetically modified with a tolerance to dicamba and glyphosate herbicides, were recently approved for import by the European Union. Monsanto planned to introduce Xtend soybeans in Canada for the […] Read more
Japan, Korea block certain U.S. wheat varieties
Chicago | Reuters — Japan and South Korea have both taken steps to block certain imports of U.S. wheat after unapproved genetically-modified (GMO) plants from Monsanto seeds were found growing in Washington state, a spokeswoman for the U.S. Department of Agriculture (USDA) said on Monday. Japan’s Ministry of Agriculture, Fisheries and Forestry said it will […] Read more
EU approves Monsanto Roundup Ready 2 Xtend beans
Reuters — The European Commission on Friday approved imports of Monsanto’s Roundup Ready 2 Xtend genetically modified soybeans, opening up an important export market for North American soybeans and easing their global rollout. The decision removes a hurdle for Monsanto in its dealings with farmers and grain traders, who have to keep track of whether […] Read more
Monsanto says no to $64-billion question
Monsanto says Bayer's latest bid financially inadequate, but open to talks
(Reuters) — U.S. seed company Monsanto Co turned down a sweetened $64 billion acquisition offer from Bayer AG, but said it was open to further talks with the German healthcare and chemicals group as well as other parties. The widely expected rejection puts pressure on Bayer to sweeten its offer once again, at least enough […] Read more